What is Serum Aldolase?
Serum aldolase is a glycolytic enzyme measured in blood that serves as a biomarker for muscle damage (particularly in inflammatory myopathies like dermatomyositis and polymyositis), liver injury, and certain malignancies.
Biochemical Background
Aldolase is a 160 kDa enzyme critical for glucose metabolism, existing in three isoenzyme forms 1:
- Aldolase A: Predominant in skeletal muscle and red blood cells
- Aldolase B: Predominant in liver, kidney, and intestine
- Aldolase C: Predominant in brain tissue
Primary Clinical Applications
Muscle Disease Assessment
Serum aldolase is most clinically valuable as a marker of inflammatory myopathies, particularly when integrated into standardized response criteria. The 2016 ACR/EULAR criteria for dermatomyositis and polymyositis specifically include aldolase among the core serum muscle enzymes (alongside CK, AST, ALT, and LDH) used to assess disease activity and treatment response 2, 3.
Key points for muscle disease:
- Elevated aldolase A isoenzyme indicates muscle damage in progressive muscular dystrophy, polymyositis, and dermatomyositis 1
- In myocardial infarction, aldolase rises within 24-48 hours and normalizes within 5 days 1
- Isolated aldolase elevation with normal CK represents a distinct pattern seen in dermatomyositis (most common), overlap myositis, and immune-mediated myopathy with perimysial pathology 4
Dermatomyositis with Normal CK: A Unique Phenotype
When aldolase is elevated but CK is normal in dermatomyositis, expect these distinguishing features 4:
- Less frequent cutaneous involvement (50% vs. 100%)
- Fewer fibrillation potentials on EMG (50% vs. 90.5%)
- Higher ESR (median 33.5 vs. 13.5 mm/h)
- More common perifascicular mitochondrial pathology (37.5% vs. 4.2%)
Liver Disease Assessment
Aldolase B isoenzyme serves as a sensitive marker of hepatocellular damage 5:
- Normal serum aldolase B: 21-39 ng/mL (mean 28.7 ± 8.6 ng/mL)
- 95% of patients with acute/chronic hepatitis without cirrhosis show elevated aldolase B (>40 ng/mL) 5
- Correlates closely with ALT (r = 0.951) and total aldolase activity (r = 0.967) 5
- Distinguishes hepatic from cardiac damage effectively 6
Malignancy Detection
Aldolase A elevation can indicate malignant liver involvement 7:
- 94% of patients with liver cell carcinoma (32/34) show elevated aldolase A
- 100% of patients with metastatic liver carcinoma (29/29) show elevation
- More sensitive than alpha-fetoprotein for primary hepatocellular carcinoma 7
- Only slightly elevated in 58% of liver metastases, not elevated in cancers without liver involvement 5
Interpretation Guidelines for Myositis Response Criteria
When using aldolase to assess treatment response in dermatomyositis/polymyositis 2:
Reference ranges for calculation:
- Aldolase: 6 times the upper limit of normal (adult DM/PM)
- Aldolase: 6 times the upper limit of normal (juvenile DM)
The most abnormal enzyme at baseline (among CK, aldolase, LDH, AST, ALT) is tracked for response assessment, with improvement scored based on absolute percentage change.
Important Caveats
- Hemolytic anemia causes falsely elevated aldolase due to red blood cell aldolase A release 1
- Athletes at rest have physiologically higher aldolase A levels due to increased muscle mass 8
- Exercise-induced elevation reflects aldolase A release, not aldolase B, and does not correlate with intravascular hemolysis 8
- Aldolase deficiency syndromes (glycogen storage disease type XII from aldolase A deficiency) present with rhabdomyolysis and hemolytic anemia 9